Falnidamol
Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. It displays >1000-fold lower potency against ErbB2 (IC50=3.4 μM) and other related tyrosine kinases (IC50>10 μM) . Falnidamol is a pyrimido-pyrimidine compound and exhibits anti-cancer activity.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
387.84
Molecular Formula
C18H19ClFN7
Notes
Research use only, not for human use.
Receptor
EGFR
CAS Number
196612-93-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS642403-01 0.05 mg
ENPP7 (NPP-7, UNQ3077/PRO9912, Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 7, Alkaline Sphingomyelin Phosphodiesterase, Intestinal Alkaline Sphingomyelinase, Alk-SMase, E-NPP 7, MGC50179)
Ask
View Details 
MBS642403-02 5x 0.05 mg
ENPP7 (NPP-7, UNQ3077/PRO9912, Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 7, Alkaline Sphingomyelin Phosphodiesterase, Intestinal Alkaline Sphingomyelinase, Alk-SMase, E-NPP 7, MGC50179)
Ask
View Details